Items where Subject is "QR180 Immunology"

Library of Congress subjects (102781) Q Science (5101) QR Microbiology (45) QR180 Immunology (16)
Number of items at this level: 16.
2026
  • Antonini, Marcello, Goldzahl, Léontine, Sicsic, Jonathan (2026). Vaccine or policy attributes? Unpacking the drivers of vaccine acceptance in France. Health Policy and Technology, 15(3). https://doi.org/10.1016/j.hlpt.2026.101164
  • Zhang, Emily H, Osipenko, Leeza, Hickman, John A (2026). Human and financial consequences of herding in oncology drug development: clinical trials of TIGIT inhibitors. BMJ Oncology, 5(1). https://doi.org/10.1136/bmjonc-2025-001037
    • 2023
  • Bertisch, Barbara, Schaetti, Christian, Schmid, Patrick, Peter, Laura, Vernazza, Pietro, Isler, Marc, Oppliger, Robert, Schmidt, Axel Jeremias (2023). Chronic hepatitis C virus infections in Switzerland in 2020: lower than expected and suggesting achievement of WHO elimination targets. Journal of Viral Hepatitis, 30(8), 667 - 684. https://doi.org/10.1111/jvh.13842 picture_as_pdf
  • Cirera, Laia, Sacoor, Charfudin, Meremikwu, Martin, Ranaivo, Louise, F. Manun’Ebo, Manu, Arikpo, Dachi, Matavele, Osvaldo, Rafaralahy, Victor, Ndombe, Didier & Pons Duran, Clara et al (2023). The economic costs of malaria in pregnancy: evidence from four sub-Saharan countries. Gates Open Research, 7, p. 47. https://doi.org/10.12688/gatesopenres.14375.2 picture_as_pdf
  • Griesel, Rulan, Zhao, Ying, Simmons, Bryony, Omar, Zaayid, Wiesner, Lubbe, Keene, Claire M., Hill, Andrew M., Meintjes, Graeme, Maartens, Gary (2023). Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB) a phase 2, non-comparative, randomised controlled trial. The Lancet HIV, 10(7), e433 - e441. https://doi.org/10.1016/S2352-3018(23)00081-4 picture_as_pdf
  • McPhedran, Robert, Cornel, Pieter, Yang, Yuchen, Devarajan, Sanjeev, Toombs, Ben, Mohideen, Anya, Rayner, Alice, Jones, Phil, Gold, Natalie (2023). Does proactively asking about allergens before ordering improve customer outcomes? An in-business randomised controlled trial. Clinical and Experimental Allergy, 53(8), 866 - 869. https://doi.org/10.1111/cea.14326 picture_as_pdf
  • Nikoloski, Zlatko, Aliyev, Elnur, Bain, Robert E.S., Menchini, Leonardo, Hegazi, Sahar, Zalkha, Mai, Mouawad, Shaza, Kapil, Neha, Gillespie, Amaya M. (2023). COVID-19 vaccination personas in Syria: evidence from a cross-sectional survey. Vaccines, 11(6). https://doi.org/10.3390/vaccines11061109 picture_as_pdf
  • Nikoloski, Zlatko, Chimenya, Dennis, Alshehari, Abdullah, Hassan, Hauwa, Bain, Robert, Menchini, Leonardo, Gillespie, Amaya (2023). COVID-19 vaccination personas in Yemen: insights from three rounds of a cross-sectional survey. Vaccines, 11(7). https://doi.org/10.3390/vaccines11071272 picture_as_pdf
    • 2022
  • Pelzer, Puck T., Seeley, Janet, Sun, Fiona Yueqian, Tameris, Michele, Tao, Li, Yanlin, Zhao, Moosan, Hisham, Weerasuriya, Chathika, Asaria, Miqdad & Jayawardana, Sahan et al (2022). Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines. PLOS Global Public Health, 2(5). https://doi.org/10.1371/journal.pgph.0000076 picture_as_pdf
    • 2021
  • Christen, Paula, Conteh, Lesong (2021). How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? BMJ Global Health, 6(9). https://doi.org/10.1136/bmjgh-2021-006827 picture_as_pdf
  • Harman, Sophie, Erfani, Parsa, Goronga, Tinashe, Hickel, Jason, Morse, Michelle, Richardson, Eugene T. (2021). Global vaccine equity demands reparative justice-not charity. BMJ Global Health, 6(6), e006504. https://doi.org/10.1136/bmjgh-2021-006504 picture_as_pdf
    • 2014
  • Coulter, Steve (2014). The war over drugs: what’s at stake?
  • Luyten, Jeroen, Ogunjimi, Benson, Beutels, Philippe (2014). Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. Vaccine, 32(52), 7175-7178. https://doi.org/10.1016/j.vaccine.2014.10.015
    • 2011
  • Morel, Chantal M. (2011-05-23) Exploring responses to the need for new antibiotics: how do different incentives compare? [Paper]. Collaboration for Innovation: The Urgent Need for New Antibiotics (ReAct policy seminar), Brussels, Belgium, BEL.
    • 2010
  • Scalvini, Marco (2010). How even the best papers still misreport HIV & AIDS (guest-blog).
    • 2007
  • Beckett, Charlie (2007). MMR, the media and risk.
    • This list was generated on Sun Mar 15 04:40:53 2026 GMT.